Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives

Details for Australian Patent Application No. 2005267051 (hide)

Owner Pharmasset Inc.

Inventors Du, Jinfa; Chun, Byoung-Kwon; Shi, Junxing; Clark, Jeremy; Wang, Peiyuan

Agent Wrays

Pub. Number AU-B-2005267051

PCT Pub. Number WO2006/012440

Priority 60/589,866 21.07.04 US; 60/608,320 09.09.04 US

Filing date 21 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 14 July 2011

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

C07H 5/04 (2006.01) Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

C07H 5/06 (2006.01) Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

C07H 19/00 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C08B 37/00 (2006.01) Preparation of polysaccharides not provided for in

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012440 Priority application(s): WO2006/012440

14 July 2011 Application Accepted

  Published as AU-B-2005267051

25 August 2011 Application for Amendment

  The nature of the amendment is: Amend the priority details to read 60/589,866 21 Jul 2004 US and 60/608,230 09 Sep 2004 US. Address for service in Australia - Wrays 56 Ord Street West Perth WA 6005

15 December 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read 60/589,866 21 Jul 2004 US and 60/608,230 09 Sep 2004 US 2005276189 Nehls, R. The nature of the amendment is as shown in the statement(s) filed 20 Jun 2011 and 05 July 2011

22 December 2011 Standard Patent Sealed

17 May 2012 Alteration of Name

  The name of the patentee has been altered to Gilead Pharmasset LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267054-(R/S) rifamycin derivatives, their preparation and pharmaceutical compositions

2005267039-Swing lock mechanism